Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy
- PMID: 25498300
- DOI: 10.1016/j.jdiacomp.2014.10.013
Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy
Abstract
Aims: Diabetic peripheral neuropathy (DPN) accompanied by painful symptoms is known as painful DPN (pDPN). This study characterized healthcare resource utilization and costs in patients with DPN, pDPN, and severe pDPN relative to diabetes only.
Methods: Four adult cohorts were identified from the Humedica database: type 2 diabetes without DPN (n=288,328); DPN (n=35,050); pDPN (DPN subjects with a pain score ≥1 on a 0-10 numeric rating scale; n=3449); and severe pDPN (pain scores 7-10; n=1824). Resource utilization and costs for 12-months post-diagnosis were compared for diabetes relative to the other cohorts.
Results: Demographic characteristics were different across cohorts. Relative to diabetes alone, DPN, pDPN, and severe pDPN were characterized by significantly higher proportions of patients with resource utilization for all resource categories (all P<0.0001); the highest resource use generally observed for severe pDPN. Total annual direct medical costs were $6632 for diabetes only, with costs for DPN ($12,492), pDPN ($27,931), and severe pDPN ($30,755) significantly higher (all P<0.0001); outpatient costs were consistently the primary driver of total costs.
Conclusions: Patients with DPN, pDPN, and severe pDPN had significantly greater healthcare resource utilization and costs than patients with diabetes only, with the highest burden associated with severe pDPN.
Keywords: Costs; Diabetes; Electronic medical records; Healthcare utilization; Pain severity; Painful diabetic peripheral neuropathy.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.Curr Med Res Opin. 2009 Jun;25(6):1319-28. doi: 10.1185/03007990902864749. Curr Med Res Opin. 2009. PMID: 19419344
-
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy.Endocrine. 2024 Dec;86(3):1014-1024. doi: 10.1007/s12020-024-03954-6. Epub 2024 Jul 13. Endocrine. 2024. PMID: 39001927 Free PMC article.
-
Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.Pain Pract. 2012 Mar;12(3):209-18. doi: 10.1111/j.1533-2500.2011.00478.x. Epub 2011 Jun 16. Pain Pract. 2012. PMID: 21676163
-
Diabetic neuropathy and painful diabetic neuropathy: Cinderella complications in South East Asia.J Pak Med Assoc. 2018 Jan;68(1):85-89. J Pak Med Assoc. 2018. PMID: 29371725 Review.
-
Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy.Clin Ther. 2021 Sep;43(9):1441-1456. doi: 10.1016/j.clinthera.2021.03.020. Epub 2021 Apr 24. Clin Ther. 2021. PMID: 33906790 Review.
Cited by
-
Challenges of neuropathic pain: focus on diabetic neuropathy.J Neural Transm (Vienna). 2020 Apr;127(4):589-624. doi: 10.1007/s00702-020-02145-7. Epub 2020 Feb 8. J Neural Transm (Vienna). 2020. PMID: 32036431 Free PMC article. Review.
-
Painful diabetic peripheral neuropathy: Health care costs and complications from 2010 to 2015.Neurol Clin Pract. 2020 Feb;10(1):47-57. doi: 10.1212/CPJ.0000000000000671. Neurol Clin Pract. 2020. PMID: 32190420 Free PMC article.
-
Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.Diabetes. 2020 May;69(5):1000-1010. doi: 10.2337/db19-1046. Epub 2020 Feb 12. Diabetes. 2020. PMID: 32051148 Free PMC article.
-
Acupuncture treatment of diabetic peripheral neuropathy: An overview of systematic reviews.J Clin Pharm Ther. 2021 Jun;46(3):585-598. doi: 10.1111/jcpt.13351. Epub 2021 Jan 28. J Clin Pharm Ther. 2021. PMID: 33511675 Free PMC article. Review.
-
Improvement of Gait after 4 Weeks of Wearable Focal Muscle Vibration Therapy for Individuals with Diabetic Peripheral Neuropathy.J Clin Med. 2020 Nov 22;9(11):3767. doi: 10.3390/jcm9113767. J Clin Med. 2020. PMID: 33266464 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical